Neuroscientist Colin Blakemore Dies at 78

The prolific science communicator specialized in studies of vision and brain plasticity and was the focus of threats from animal rights extremists for several years.

| 2 min read
Colin Blakemore

University of Oxford

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Colin Blakemore, a science communicator and pioneering neuroscientist who was among the first researchers to explain brain plasticity, died on June 27 at the age of 78 after receiving hospice care for motor neuron disease, his daughter Sarah-Jayne announced via Twitter.

Born June 1, 1944, in Stratford-Upon-Avon in England, Colin Blakemore showed academic aptitude early on. According to a tribute from the University of Oxford, Blakemore received a state scholarship to attend Cambridge University’s Corpus Christi College. He studied medical sciences and graduated with honors in 1965. He took only two and a half years after his graduation to earn his PhD in physiological optics from the University of California, Berkeley.

At age 24, he became a lecturer at the University of Oxford, where he would later be promoted to professor and fellow. He studied brain development, including binocular depth perception and spatial awareness, showing how vision developed and demonstrating the brain’s plasticity in making neural connections.

Blakemore was often the target of animal rights activists due to the nature of his studies, which involved restricting animals’ sight by sewing their eyes shut. Though he anesthetized the animals and used the same techniques performed on human babies with eye injuries, he faced harassment from extremists for years, including threats to kidnap his children. Once, a package addressed to his daughters arrived at his house containing a bomb covered in purportedly HIV-tainted needles. Yet he continued his research and repeatedly tried to engage with the protesters.

“Research on animals is evil,” Blakemore told The Scientist in 2002, “but a necessary evil if it is balanced against the benefits that accrue.” According to The Guardian, Blakemore joined the Boyd Group think tank in the early 1990s, providing researchers and nonviolent animal rights activists a space to discuss the issue.

In 2003, Blakemore became chief of Britain’s Medical Research Council (MRC). Though all of his predecessors had received a knighthood upon taking that position, he was repeatedly denied that honor because of his unwavering support for animal experimentation. He famously threatened to resign from his position if “political expediency” on a controversial subject would take precedence over honoring objective merit. He was involved in further controversy in 2005 when there were rumors he threatened to fire a scientist at the National Institute for Medical Research, one of the MRC’s flagship institutions, who did not support certain decisions, though he was ultimately cleared of any wrongdoing. Blakemore stepped down from the MRC in 2007.

In 2012, he retired from Oxford as a professor emeritus. Among his many awards and honorifics, he finally received a knighthood in 2014.

“So many of the tributes to Colin have focused on his bravery,” writes journalist Fiona Fox in a blog post for Science Media Centre recounting some the more harrowing aspects of the harassment he endured, “and I sense that we find Colin’s death harder to take because so few of us feel able to emulate his courage.”

He is preceded in death by his wife Andrée Elizabeth Washbourne, whom he met as a teenager. He is survived by his three daughters.

Keywords

Meet the Author

  • Lisa Winter

    Lisa Winter became social media editor for The Scientist in 2017. In addition to her duties on social media platforms, she also pens obituaries for the website. She graduated from Arizona State University, where she studied genetics, cell, and developmental biology.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo